Searched for
AMEESH MASUREKAR
Big boys of India's pharmaceutical industry may reshape Indian e-pharmaIndia's $20-billion pharmaceutical industry is set for a shakeup as giants Reliance Retail and Amazon chart plans to enter the e-pharmacy s...- Panic buying of drugs down since mid-AprilSales of anti-infective medicines in the April 1-22 period eased to 62% from levels seen from March 1to 22. While sales of antidiabetes dru...
- Coronavirus shuts door on other viruses, sales of many drugs fallSales of anti-infectives have fallen 34% month on month so far in April while sales of respiratory drugs (excluding asthma products) have d...
- Pharma may see a price war in good news for diabeticsGlenmark launches a drug at almost half the price of those offered by rivals.
- Patented drug launches help MNCs score over Indian peersWhile Indian companies still control almost 80% of the market in the country, the strategy of launching specialised patented product is hel...
- Essential drugs to be sold at non-GST price till August"Although hospital services are exempt, the outsourced services, aesthetics and outpatient pharmacies are subject to GST imposition."
- Pharma companies still facing GST rollout bluesThe All India Organisation of Chemists and Druggists, which represents over 8 lakh chemists, has assured the government that supply of drug...
- Ahead of GST, drug inventories cutStockists, worried they may suffer losses on account of a possible mismatch between tax payouts and tax refunds once GST kicks in, have sta...
- Demonetisation: People stock up on medicines to get rid of old notesAWACs found that anti-diabetic, cardiovascular and BP drugs have shown a significant increase in sales as compared to corresponding period ...
- How does the Sun Pharma-Ranbaxy deal change the game for the other players in the Indian pharma market?The combined market share of Sun Pharma (5.4% at present) and Ranbaxy (3.8%) will be 9.2%; much higher than that of the current No. 1 playe...
- Sun Pharma-Ranbaxy combine creates a new market leader in Indian marketThe proposed new entity would unseat Abbott from the top position, which holds current market share of 6.5%, according to research firm Aio...
- Slowdown hits domestic pharma, market shrinks 1.8 per cent in SeptemberThe economic slowdown has hit the Rs 72,000- crore domestic pharma business, usually considered recession-proof.
- Domestic drug market to grow by 13 per cent in 2013: ResearchThe 72,000-crore domestic drug market could grow between 11% and 13% in 2013, according to projections by pharma market research firms.
- Pharma sector sales growth slump in December quarter“India is an under-diagnosed market, so the argument that less people are falling sick might not be true,” asserts Sujay Shetty, head of li...
- Health ministry rejects DoP’s recommendation on pricing of essential drugsThe health ministry has suggested that the pricing of essential medicines be based on either the average price of the three cheapest brands...
- Indian drugmakers post 21% growth in November sales: AIOCDIndian drugmakers posted 21% month-on-month growth in November sales, which was the highest in the past 14 months
- New pharma pricing policy to cost manufacturers Rs 1,500 crore: StudyThe proposed national drug pricing policy will cost drugmakers close to 1,500 crore and stockists and traders collectively over 2,500 crore...
Load More
